Elizabeth Hohmann
Physician · Massachusetts General Hospital
Credentials: · · ·
History
- 1993–1994
- 1986–1989
- 1982–1986
Research
Remdesivir for the Treatment of Covid-19 - Final Report
New England Journal of Medicine · 2020 · 5,321 citations
Drug-Resistant E. coli Bacteremia Transmitted by Fecal Microbiota Transplant
Case report · New England Journal of Medicine · 2019 · Last of 10 authors · 1,001 citations
Review · Clinical Infectious Diseases · 2001 · Sole author · 768 citations
- HW
8 papers
8 papers
- IY
7 papers
6 papers · 6 as a resident
6 papers
- SC
6 papers
- BM
5 papers
5 papers
Grants
- 2024–2027
Fecal Microbiota Transplantation for Auto-Brewery Syndrome
National Institute on Alcohol Abuse and Alcoholism · R21
PI · $444.9K · University of California, San Diego
- 2010–2012
Collaborative IRB Review and Ethical/Educational Exchange - Boston/Durban
Fogarty International Center · S07
Contact PI · $49.7K · Massachusetts General Hospital
- 2005–2011
Human Studies of Attenuated Salmonella Vectors
National Institute of Allergy and Infectious Diseases · R01
Contact PI · $1.5M · Massachusetts General Hospital
- 2002–2010
Human Studies of Listeria Monocytogenes Vectors
National Institute of Allergy and Infectious Diseases · R01
Contact PI · $2M · Massachusetts General Hospital
Clinical trials
- 2025–2030
Fecal Microbiota Transplant for Autobrewery Syndrome
Principal investigator · Active not recruiting · Early phase 1
Massachusetts General Hospital
- 2015–2016
Principal investigator · Terminated · Phase 1
Massachusetts General Hospital
- 2013–2014
Principal investigator · Completed · Phase 1
Massachusetts General Hospital
- 2012–2014
Principal investigator · Completed · Phase 1
Massachusetts General Hospital